Novartis shares rise as it enters liver disease drug development deal with Pfizer
October 29th -
Novartis shares are higher as the Swiss pharma group enters an agreement with Pfizer to collaborate on the development of a drug to treat NASH liver disease.
Novartis shares rise amid plans for cancer drug specialist purchase
October 18th -
Novartis shares are higher Thursday, as the Swiss drugs maker announced the purchase of US cancer drug specialist, Endocyte and also raised its 2018 earnings guidance.
Novartis to report Q1 earnings
April 17th -
Novartis reports 1Q14 results on Thursday